AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35357352 — intervention group
Group type: COMPARATOR
Intervention: Cardiac catheter-based closure (CCC)
Number of subjects: 69
Study 34431380 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported loneliness assessment
Number of subjects: 4588
Study 34431380 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and health-related factors
Number of subjects: 4588
Study 35484697 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg + TCS
Number of subjects: 463
Study 35484697 — intervention group
Group type: COMPARATOR
Intervention: Placebo + TCS
Number of subjects: 463
Study 33563084 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for prostate cancer
Number of subjects: 0
Study 32186160 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy (30-minute sessions, 3 times weekly for 6 weeks)
Number of subjects: 102
Study 32186160 — intervention group
Group type: COMPARATOR
Intervention: Routine conventional Western Medicine treatment alone
Number of subjects: 102
Study 35252408 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless aortic valve replacement (Su-AVR)
Number of subjects: 819
Study 35252408 — intervention group
Group type: COMPARATOR
Intervention: Standard aortic valve replacement (SAVR)
Number of subjects: 819
Study 33126692 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunnelled intervention (N = 27)
Number of subjects: 71
Study 33126692 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-choice intervention (N = 27)
Number of subjects: 71
Study 33126692 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention control (N = 17)
Number of subjects: 71
Study 34400207 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrolled in HEAL trial
Number of subjects: 269
Study 34400207 — intervention group
Group type: COMPARATOR
Intervention: Declined enrollment in HEAL trial
Number of subjects: 269
Study 34400207 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrolled parents
Number of subjects: 269
Study 34400207 — intervention group
Group type: COMPARATOR
Intervention: Declined parents
Number of subjects: 269
Study 32325415 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretch with Vibration (SV)
Number of subjects: 39
Study 32325415 — intervention group
Group type: COMPARATOR
Intervention: Static Stretch (SS)
Number of subjects: 39
Study 32325415 — intervention group
Group type: COMPARATOR
Intervention: Normative (N)
Number of subjects: 39
Study 35106617 — intervention group
Group type: EXPERIMENTAL
Intervention: TDM-guided therapy (continuous infusion of piperacillin/tazobactam with dosing guided by daily TDM)
Number of subjects: 254
Study 35106617 — intervention group
Group type: COMPARATOR
Intervention: Fixed dose therapy (continuous infusion of piperacillin/tazobactam at 13.5 g/24 h if eGFR ≥ 20 mL/min)
Number of subjects: 254
Study 35106617 — intervention group
Group type: EXPERIMENTAL
Intervention: TDM-guided therapy
Number of subjects: 254
Study 35106617 — intervention group
Group type: COMPARATOR
Intervention: Fixed dose therapy
Number of subjects: 254
Study 33909732 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant survival probability for patients ≤ 70 years of age
Number of subjects: 378
Study 33909732 — intervention group
Group type: COMPARATOR
Intervention: Sex
Number of subjects: 378
Study 33909732 — intervention group
Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 378
Study 33909732 — intervention group
Group type: COMPARATOR
Intervention: Diabetes
Number of subjects: 378
Study 33909732 — intervention group
Group type: COMPARATOR
Intervention: Arch location
Number of subjects: 378
Study 35351531 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole prophylaxis
Number of subjects: 2848
Study 35351531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2848
Study 33829551 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-operator cholangioscopy-guided biopsy (SpyGlassDS)
Number of subjects: 100
Study 33248581 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnSO4 treatment: 80 mg zinc/kg from ZnSO4
Number of subjects: 180
Study 33248581 — intervention group
Group type: EXPERIMENTAL
Intervention: ISO treatment: 40 mg zinc/kg from ZnSO4 plus 40 mg zinc/kg from a zinc-amino acid complex
Number of subjects: 180
Study 33248581 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic treatment: 40 mg zinc/kg from a zinc-amino acid complex
Number of subjects: 180
Study 36427446 — intervention group
Group type: EXPERIMENTAL
Intervention: Video version 1
Number of subjects: 4697
Study 36427446 — intervention group
Group type: EXPERIMENTAL
Intervention: Video version 2
Number of subjects: 4697
Study 36427446 — intervention group
Group type: COMPARATOR
Intervention: Positively framed videos
Number of subjects: 4697
Study 36427446 — intervention group
Group type: COMPARATOR
Intervention: Negatively framed videos
Number of subjects: 4697
Study 35648794 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 40mg for 5 days
Number of subjects: 249
Study 35648794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study 35301592 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 0
Study 34375844 — intervention group
Group type: EXPERIMENTAL
Intervention: Random schedule of practice
Number of subjects: 84
Study 34375844 — intervention group
Group type: COMPARATOR
Intervention: Blocked schedule of practice
Number of subjects: 84
Study 34375844 — intervention group
Group type: EXPERIMENTAL
Intervention: Error estimation
Number of subjects: 84
Study 34375844 — intervention group
Group type: COMPARATOR
Intervention: No error estimation
Number of subjects: 84
Study 32759193 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 400 IU and 500 mg of calcium carbonate twice a day for 1 year
Number of subjects: 1050
Study 32759193 — intervention group
Group type: COMPARATOR
Intervention: Observation group (no vitamin D evaluation or supplementation)
Number of subjects: 1050
Study 32759193 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation
Number of subjects: 1050
Study 33277370 — intervention group
Group type: EXPERIMENTAL
Intervention: GVAX alone
Number of subjects: 87
Study 33277370 — intervention group
Group type: EXPERIMENTAL
Intervention: GVAX with low-dose oral cyclophosphamide
Number of subjects: 87
Study 33277370 — intervention group
Group type: COMPARATOR
Intervention: Historical controls who received adjuvant GVAX alone
Number of subjects: 87
Study 33277370 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher density of intratumoral tertiary lymphoid aggregates (TLA)
Number of subjects: 87
Study 33525212 — intervention group
Group type: EXPERIMENTAL
Intervention: SOF/LDP 400/100 mg daily plus standard of care (n=42)
Number of subjects: 82
Study 33525212 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone (control group, n=40)
Number of subjects: 82
Study 33781620 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 Mile Club
Number of subjects: 1008
Study 33781620 — intervention group
Group type: EXPERIMENTAL
Intervention: Just Move
Number of subjects: 1008
Study 33781620 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1008
Study 33781620 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1008
Study 33348685 — intervention group
Group type: EXPERIMENTAL
Intervention: 280 g/day of frozen raspberries for 8 weeks
Number of subjects: 59
Study 33348685 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 59
Study 35512068 — intervention group
Group type: EXPERIMENTAL
Intervention: α lipoic acid combined with olmesartan medoxomil
Number of subjects: 0
Study 35512068 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan medoxomil combined with placebo
Number of subjects: 0
Study 33862811 — intervention group
Group type: EXPERIMENTAL
Intervention: Local logarithmic export distributions by destinations and products
Number of subjects: 0
Study 33862811 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-degree of the exporter and in-degrees of destinations or products
Number of subjects: 0
Study 34023888 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led alcohol guidance intervention
Number of subjects: 53
Study 34023888 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study 32062021 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitspiration images
Number of subjects: 108
Study 32062021 — intervention group
Group type: COMPARATOR
Intervention: Travel inspiration images
Number of subjects: 108
Study 32062021 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise following fitspiration images
Number of subjects: 108
Study 32062021 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet rest following fitspiration images
Number of subjects: 108
Study 35660514 — intervention group
Group type: EXPERIMENTAL
Intervention: Situation-focused reappraisal
Number of subjects: 44
Study 35660514 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-focused reappraisal
Number of subjects: 44
Study 34564920 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Learning Object (VLO) for undergraduate dental students (VLOG)
Number of subjects: 220
Study 34564920 — intervention group
Group type: COMPARATOR
Intervention: Synchronous virtual class (Control Group - CG)
Number of subjects: 220
Study 34564920 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Learning Object (VLO) for paediatric dentists (PDG)
Number of subjects: 220
Study 32037583 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based virtual patient training (n=36)
Number of subjects: 76
Study 32037583 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face case-based training (n=40)
Number of subjects: 76
Study 35512619 — intervention group
Group type: EXPERIMENTAL
Intervention: BST stimulation (left, right, bilateral)
Number of subjects: 9
Study 35512619 — intervention group
Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 9
Study 35984916 — intervention group
Group type: EXPERIMENTAL
Intervention: Staying Strong & Healthy intervention (education, exercise, and nutrition)
Number of subjects: 0
Study 35984916 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study 36395521 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-source ultrasound trainer (OSUT) in addition to an ultrasound system
Number of subjects: 24
Study 36395521 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound system (control group)
Number of subjects: 24
Study 34182749 — intervention group
Group type: EXPERIMENTAL
Intervention: AFCNB + FTB
Number of subjects: 80
Study 34182749 — intervention group
Group type: COMPARATOR
Intervention: FTB
Number of subjects: 80
Study 32751720 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Core Exercise (DCE)
Number of subjects: 52
Study 32751720 — intervention group
Group type: COMPARATOR
Intervention: General Physical Education (GPE)
Number of subjects: 52
Study 34837121 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment 14 days prior to surgery
Number of subjects: 54
Study 34837121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 32164634 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-category lower calorie labels
Number of subjects: 146
Study 32164634 — intervention group
Group type: EXPERIMENTAL
Intervention: Across-category lower calorie labels
Number of subjects: 146
Study 32164634 — intervention group
Group type: COMPARATOR
Intervention: Control (no labeling)
Number of subjects: 146
Study 32164634 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-category lower calorie labels (beverages)
Number of subjects: 146
Study 32164634 — intervention group
Group type: EXPERIMENTAL
Intervention: Across-category lower calorie labels (beverages)
Number of subjects: 146
Study 35416793 — intervention group
Group type: EXPERIMENTAL
Intervention: Pickle juice
Number of subjects: 82
Study 35416793 — intervention group
Group type: COMPARATOR
Intervention: Tap water (Control)
Number of subjects: 82
Study 33992656 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI)
Number of subjects: 11701
Study 33186867 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive research
Number of subjects: 100
Study 33186867 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive research
Number of subjects: 100
Study 33186867 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanatory research
Number of subjects: 100
Study 33186867 — intervention group
Group type: EXPERIMENTAL
Intervention: Research designs
Number of subjects: 100
Study 33186867 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative techniques
Number of subjects: 100
Study 35152536 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injection of vitamin D3 (1ml every 4 weeks for a maximum of 3 sessions)
Number of subjects: 60
Study 35152536 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 0.9% (control group, 1ml every 4 weeks for 3 sessions)
Number of subjects: 60
Study 32991361 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Disk Arthroplasty (CDA)
Number of subjects: 397
Study 32991361 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 397
Study 32991361 — intervention group
Group type: COMPARATOR
Intervention: Control (Preoperative condition)
Number of subjects: 397
Study 32991361 — intervention group
Group type: COMPARATOR
Intervention: Postoperative condition at 10 years
Number of subjects: 397
Study 36118833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT) combined with Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 92
Study 36118833 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 92
Study 32409691 — intervention group
Group type: EXPERIMENTAL
Intervention: isatuximab 3 mg/kg every 2 weeks (Q2W)
Number of subjects: 97
Study 32409691 — intervention group
Group type: EXPERIMENTAL
Intervention: isatuximab 10 mg/kg Q2W/Q4W
Number of subjects: 97
Study 32409691 — intervention group
Group type: EXPERIMENTAL
Intervention: isatuximab 10 mg/kg Q2W
Number of subjects: 97
Study 32409691 — intervention group
Group type: EXPERIMENTAL
Intervention: isatuximab 20 mg/kg QW(1 cycle)/Q2W
Number of subjects: 97
Study 32409691 — intervention group
Group type: EXPERIMENTAL
Intervention: isatuximab (doses ≥10 mg/kg)
Number of subjects: 97
Study 32409691 — intervention group
Group type: EXPERIMENTAL
Intervention: non-hematologic adverse events
Number of subjects: 97
Study 36364803 — intervention group
Group type: EXPERIMENTAL
Intervention: R24W
Number of subjects: 68
Study 36364803 — intervention group
Group type: COMPARATOR
Intervention: ASA24-Canada-2018
Number of subjects: 68
Study 36364803 — intervention group
Group type: COMPARATOR
Intervention: R24W and ASA24-Canada-2018
Number of subjects: 68
Study 33087074 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine follow-up care
Number of subjects: 182
Study 33087074 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient care
Number of subjects: 182
Study 32090656 — intervention group
Group type: EXPERIMENTAL
Intervention: Collective venue avoidance through social mechanisms (homophily and popular opinion leaders)
Number of subjects: 468
Study 33969614 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone (placebo)
Number of subjects: 711
Study 32961119 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks for four doses, then every 12 weeks until 1 year or until disease recurrence, unacceptable toxicity, or withdrawal)
Number of subjects: 906
Study 32961119 — intervention group
Group type: COMPARATOR
Intervention: Ipilimumab (10 mg/kg every 3 weeks for four doses, then every 12 weeks until 1 year or until disease recurrence, unacceptable toxicity, or withdrawal)
Number of subjects: 906
Study 32961119 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 906
Study 32961119 — intervention group
Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 906
Study 36462120 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Regain (WR) group (Group A)
Number of subjects: 88
Study 36462120 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Loss group (Group B)
Number of subjects: 88
Study 36462120 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 88
Study 34049396 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher carbohydrate diets (58% kcal)
Number of subjects: 163
Study 34049396 — intervention group
Group type: COMPARATOR
Intervention: Lower carbohydrate diets (40% kcal)
Number of subjects: 163
Study 34049396 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher GI diets (≥65)
Number of subjects: 163
Study 33408120 — intervention group
Group type: EXPERIMENTAL
Intervention: +F+H
Number of subjects: 88
Study 33408120 — intervention group
Group type: EXPERIMENTAL
Intervention: +F-H
Number of subjects: 88
Study 33408120 — intervention group
Group type: EXPERIMENTAL
Intervention: -F+H
Number of subjects: 88
Study 33408120 — intervention group
Group type: COMPARATOR
Intervention: -F-H
Number of subjects: 88
Study 34000629 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing progressive resistive quadriceps exercise
Number of subjects: 17
Study 34000629 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 17
Study 36251472 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal-tragus length based formula (NTL + 1 cm)
Number of subjects: 120
Study 36251472 — intervention group
Group type: COMPARATOR
Intervention: Weight based formula (Weight + 6 cm)
Number of subjects: 120
Study 33259001 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT
Number of subjects: 689
Study 33259001 — intervention group
Group type: COMPARATOR
Intervention: CMF
Number of subjects: 689
Study 33259001 — intervention group
Group type: EXPERIMENTAL
Intervention: TILs high
Number of subjects: 689
Study 36174848 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (60,000 IU of vitamin D3 once per month for up to 5 years)
Number of subjects: 19925
Study 36174848 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral once per month for up to 5 years)
Number of subjects: 19925
Study 36174848 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 19925
Study 36174848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19925
Study 33977364 — intervention group
Group type: EXPERIMENTAL
Intervention: ModelCI (combination of clinical factors and imaging characteristics)
Number of subjects: 185
Study 33977364 — intervention group
Group type: EXPERIMENTAL
Intervention: ModelC (clinical factors)
Number of subjects: 185
Study 33977364 — intervention group
Group type: EXPERIMENTAL
Intervention: ModelI (imaging characteristics)
Number of subjects: 185
Study 33977364 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score ≥ 0.88 (high-risk subgroup)
Number of subjects: 185
Study 35244287 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant follicle-stimulating hormone (rFSH) at doses of 0.5, 1.1, and 2.2 IU/kg/d
Number of subjects: 30
Study 35244287 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant follicle-stimulating hormone (rFSH) at all doses
Number of subjects: 30
Study 32267573 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicagrel (24 mg loading dose, 6 mg maintenance dose)
Number of subjects: 48
Study 32267573 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (300 mg loading dose, 75 mg maintenance dose)
Number of subjects: 48
Study 33538934 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention adjuncts (VIAs) paired with dialectical behavior therapy (DBT) for IPV skills group
Number of subjects: 24
Study 33538934 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no VIAs)
Number of subjects: 24
Study 33527139 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-Release Hydrocortisone (MR-HC)
Number of subjects: 122
Study 33527139 — intervention group
Group type: COMPARATOR
Intervention: Standard glucocorticoid therapy
Number of subjects: 122
Study 33539373 — intervention group
Group type: EXPERIMENTAL
Intervention: Public Opinion Survey of Human Attributes-Stuttering (POSHA-S)
Number of subjects: 650
Study 33539373 — intervention group
Group type: EXPERIMENTAL
Intervention: Income level (average to high)
Number of subjects: 650
Study 33232866 — intervention group
Group type: COMPARATOR
Intervention: Footwear conditions (various types)
Number of subjects: 75
Study 32105820 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2α (PGF2α) injection into the cervix before and after surgery
Number of subjects: 44
Study 32105820 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2α (PGF2α) injection
Number of subjects: 44
Study 32105820 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PGF2α injection)
Number of subjects: 44
Study 35157055 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE), 4 g/d
Number of subjects: 8179
Study 35157055 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 8179
Study 33733911 — intervention group
Group type: EXPERIMENTAL
Intervention: Stay Safe Link® (SSL)
Number of subjects: 472
Study 33733911 — intervention group
Group type: COMPARATOR
Intervention: Stay Safe® (STS)
Number of subjects: 472
Study 32176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based nursing (EBN) intervention
Number of subjects: 126
Study 32176044 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative radiotherapy
Number of subjects: 126
Study 35143628 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrorectus mesh group (self-gripping prophylactic mesh)
Number of subjects: 244
Study 35143628 — intervention group
Group type: COMPARATOR
Intervention: No mesh (control group)
Number of subjects: 244
Study 33631356 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Usual Care
Number of subjects: 1200
Study 33631356 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care
Number of subjects: 1200
Study 33631356 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care Plus
Number of subjects: 1200
Study 35802375 — intervention group
Group type: EXPERIMENTAL
Intervention: 195-mg transdermal cannabidiol
Number of subjects: 188
Study 35802375 — intervention group
Group type: EXPERIMENTAL
Intervention: 390-mg transdermal cannabidiol
Number of subjects: 188
Study 35802375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 35802375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (combined 195-mg and 390-mg)
Number of subjects: 188